Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tijana Randic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|June 7, 2021
NRAS mutant melanoma: Towards better therapiesTijana Randic, Ines Kozar, Christiane Margue, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
UHRF1 Overexpression Generates Distinct Senescent States with Different Tp53 DependenciesElena Magnani, Charlene Chen, Filippo Macchi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor HeterogeneityElena Magnani, Filippo Macchi, Tijana Randic, et al.
Cell Reports|June 28, 2023
Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug responseTijana Randic, Stefano Magni, Demetra Philippidou, et al.
Cancer Gene Therapy|July 7, 2023
A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanomaVincent Gureghian, Hailee Herbst, Ines Kozar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|June 7, 2021
NRAS mutant melanoma: Towards better therapiesTijana Randic, Ines Kozar, Christiane Margue, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
UHRF1 Overexpression Generates Distinct Senescent States with Different Tp53 DependenciesElena Magnani, Charlene Chen, Filippo Macchi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Epigenetic Disordering Drives Stemness, Senescence Escape and Tumor HeterogeneityElena Magnani, Filippo Macchi, Tijana Randic, et al.
Cell Reports|June 28, 2023
Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug responseTijana Randic, Stefano Magni, Demetra Philippidou, et al.
Cancer Gene Therapy|July 7, 2023
A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanomaVincent Gureghian, Hailee Herbst, Ines Kozar, et al.
Pageof 1